| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2015 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Chief Scientific Officer | Sell | 25,000 | $15.67 | $391,750.00 | -7.5% | |
| Feb 18, 2015 | MRK Merck & Co., Inc. | Frazier Kenneth C | Chairman, President &CEO | Sell | 5,164 | $58.67 | $302,958.97 | -1.4% | |
| Feb 17, 2015 | PAHC Phibro Animal Health Corp | Dagger Thomas G | SVP, Gen Counsel And Corp Sec | Sell | 4,000 | $31.91 | $127,640.00 | -100% | |
| Feb 17, 2015 | PAHC Phibro Animal Health Corp | Warras Dean J | Pres., Prince Agri Products | Sell | 4,000 | $31.90 | $127,600.00 | -100% | |
| Feb 17, 2015 | PAHC Phibro Animal Health Corp | Welch Daniel A | Sr VP, Human Resources | Sell | 4,000 | $31.90 | $127,600.00 | -100% | |
| Feb 11, 2015 | MRK Merck & Co., Inc. | Deese Willie A | Exe V-p &Pres. Mmd | Sell | 135,864 | $58.56 | $7,956,372.46 | -56.1% | |
| Feb 10, 2015 | PBH Prestige Consumer Healthcare Inc. | Mannelly Matthew | President And CEO | Sell | 17,500 | $38.69 | $677,075.00 | -22.6% | |
| Feb 10, 2015 | PBH Prestige Consumer Healthcare Inc. | Lombardi Ronald M.52 | Chief Financial Officer | Sell | 22,400 | $38.89 | $871,136.00 | -24.8% | |
| Feb 9, 2015 | MRK Merck & Co., Inc. | Wendell Peter C | Director | Sell | 5,000 | $58.76 | $293,797.00 | -83.3% | |
| Feb 6, 2015 | PCRX Pacira Biosciences, Inc. | Scibetta James S | SVP, Chief Financial Officer | Sell | 15,000 | $111.22 | $1,668,374.19 | -28.2% | |
| Feb 5, 2015 | LLY Eli Lilly & Co | Zakrowski Donald A | Chief Accounting Officer | Sell | 374 | $71.03 | $26,565.22 | -8.5% | |
| Feb 4, 2015 | LLY Eli Lilly & Co | Lundberg Jan M | EVP,Science&Tech And Pres. Lrl | Sell | 11,085 | $70.08 | $776,836.80 | -12.5% | |
| Feb 4, 2015 | LLY Eli Lilly & Co | Ricks David A51 | SVP And Pres, Lilly Bio-meds | Sell | 3,147 | $69.99 | $220,258.53 | -5.0% | |
| Feb 4, 2015 | LLY Eli Lilly & Co | Rice Derica W | Evp-global Services And CFO | Sell | 5,316 | $70.00 | $372,120.00 | -8.8% | |
| Feb 3, 2015 | LLY Eli Lilly & Co | Lundberg Jan M | EVP,Science&Tech And Pres. Lrl | Sell | 121,711 | $70.78 | $8,614,901.92 | -32.9% | |
| Feb 2, 2015 | LLY Eli Lilly & Co | Ricks David A51 | SVP And Pres, Lilly Bio-meds | Sell | 4,769 | $71.51 | $341,031.19 | -7.0% | |
| Feb 2, 2015 | LLY Eli Lilly & Co | Rice Derica W | Evp-global Services And CFO | Sell | 10,068 | $71.84 | $723,285.12 | -14.3% | |
| Jan 29, 2015 | SNY Sanofi | Sanofi | 10% Owner | Buy | 97,118 | $95.00 | $9,226,210.00 | +1.0% | |
| Jan 26, 2015 | SNY Sanofi | Sanofi | 10% Owner | Buy | 843,699 | $72.90 | $61,507,560.00 | +4.6% | |
| Jan 20, 2015 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 15,325 | $27.67 | $424,085.06 | -0.4% | |
| Jan 15, 2015 | PCRX Pacira Biosciences, Inc. | Stack David M67 | President, CEO And Chairman | Sell | 15,000 | $97.52 | $1,462,829.00 | -61.2% | |
| Jan 15, 2015 | MRK Merck & Co., Inc. | Schechter Adam H | EVP &Pres-global Human Health | Sell | 74,200 | $62.48 | $4,636,223.76 | -100% | |
| Jan 12, 2015 | PCRX Pacira Biosciences, Inc. | Hastings Paul J75 | Director | Sell | 2,500 | $94.06 | $235,150.00 | -74.6% | |
| Jan 9, 2015 | MRK Merck & Co., Inc. | Frazier Kenneth C | Chairman, President &CEO | Sell | 8,840 | $62.47 | $552,266.62 | -2.5% | |
| Jan 9, 2015 | PAHC Phibro Animal Health Corp | Mayflower L.P. | 10% Owner | Sell | 119,644 | $0.00 | - | -3.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.